Clinical Features and Treatment Outcomes of Seronegative Pediatric Autoimmune Encephalitis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background and Purpose New diagnostic criteria for pediatric autoimmune encephalitis (AIE) have been introduced recently. A substantial proportion of cases of pediatric AIE are diagnosed as seronegative based on these criteria, and so the clinical characteristics of this group remain to be investigated. Methods This study included 46 pediatric patients younger than 18 years with suspected AIE. Clinical features, laboratory or radiological findings, and treatment outcomes were compared between seronegative and seropositive patients. Results Nine (19.6%) of the 46 patients were diagnosed as seropositive AIE. All of the patients with seropositive AIE had anti-N-methyl-D-aspartate receptor antibodies. Commonly identified neuropsychiatric symptoms were altered mental status, cognitive dysfunction, seizure, speech dysfunction, and psychotic disorder in both the seronegative and seropositive groups. Immunotherapy produced favorable treatment outcomes in both the seropositive (n=7, 77.8%) and seronegative (n=35, 94.6%) AIE patients. Treatment outcomes for first-line immunotherapy were better in seronegative AIE than seropositive AIE patients (p=0.003), and hence a smaller proportion of seronegative patients required second-line treatment (p=0.015). Conclusions Pediatric seronegative AIE patients showed clinical presentations similar to those of seropositive AIE patients, with favorable treatment outcomes after immunotherapy.
Abstract
Background and Purpose New diagnostic criteria for pediatric autoimmune encephalitis (AIE) have been introduced recently. A substantial proportion of cases of pediatric AIE are diagnosed as seronegative based on these criteria, and so the clinical characteristics of this group remain to be investigated. Methods This study included 46 pediatric patients younger than 18 years with suspected AIE. Clinical features, laboratory or radiological findings, and treatment outcomes were compared between seronegative and seropositive patients. Results Nine (19.6%) of the 46 patients were diagnosed as seropositive AIE. All of the patients with seropositive AIE had anti-N-methyl-D-aspartate receptor antibodies. Commonly identified neuropsychiatric symptoms were altered mental status, cognitive dysfunction, seizure, speech dysfunction, and psychotic disorder in both the seronegative and seropositive groups. Immunotherapy produced favorable treatment outcomes in both the seropositive (n=7, 77.8%) and seronegative (n=35, 94.6%) AIE patients. Treatment outcomes for first-line immunotherapy were better in seronegative AIE than seropositive AIE patients (p=0.003), and hence a smaller proportion of seronegative patients required second-line treatment (p=0.015). Conclusions Pediatric seronegative AIE patients showed clinical presentations similar to those of seropositive AIE patients, with favorable treatment outcomes after immunotherapy.
참고문헌 (36)
- Newman MP, "Autoimmune encephalitis", Intern Med J, 46, pp.148~157 (2016)
- Esposito S, "An evolving redefinition of autoimmune encephalitis", Autoimmun Rev, 18, pp.155~163 (2019)
- Dutra LA, "Autoimmune encephalitis : a review of diagnosis and treatment", Arq Neuropsiquiatr, 76, pp.41~49 (2018)
- Dalmau J, "Antibody-mediated encephalitis", N Engl J Med, 378, pp.840~851 (2018)
- Dalmau J, "Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma", Ann Neurol, 61, pp.25~36 (2007)
- Hermetter C, "Systematic review : syndromes, early diagnosis, and treatment in autoimmune encephalitis", Front Neurol, 9, pp.706~ (2018)
- Bradshaw MJ, "An overview of autoimmune and paraneo-plastic encephalitides", Semin Neurol, 38, pp.330~343 (2018)
- Netravathi M, "Seronegative autoimmune encephalitis-a diagnostic and therapeutic dilemma", Ann Indian Acad Neurol, 22, pp.369~370 (2019)
- Ramanathan S, "Autoimmune encephalitis : recent updates and emerging challenges", J Clin Neurosci, 21, pp.722~730 (2014)
- Graus F, "A clinical approach to diagnosis of autoimmune encephalitis", Lancet Neurol, 15, pp.391~404 (2016)
- Cellucci T, "Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient", Neurol Neuroimmunol Neuroinflamm, 7, pp.e663~ (2020)
- Dale RC, "Autoimmune encephalitis in children : clinical phenomenology, therapeutics, and emerging challenges", Curr Opin Neurol, 30, pp.334~344 (2017)
- Van Mater H, "Pediatric inflammatory brain diseases : a diagnostic approach", Curr Opin Rheumatol, 26, pp.553~561 (2014)
- Hacohen Y, "Paediatric autoimmune encephalopathies : clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens", J Neurol Neurosurg Psychiatry, 84, pp.748~755 (2013)
- Remy KE, "Pediatric anti-N-methyl-d-aspartate receptor encephalitis : a review with pooled analysis and critical care emphasis", Front Pediatr, 5, pp.250~ (2017)
- Sai Y, "Clinical diagnosis and treatment of pediatric anti-N-methyl-D-aspartate receptor encephalitis : a single center retrospective study", Exp Ther Med, 16, pp.1442~1448 (2018)
- Wright SK, "Neurodevelopmental outcomes in paediatric immune-mediated and autoimmune epileptic encephalopathy", Eur J Paediatr Neurol, 24, pp.53~57 (2020)
- Thakur KT, "Predictors of outcome in acute encephalitis", Neurology, 81, pp.793~800 (2013)
- Qiu X, "Analysis of clinical characteristics and poor prognostic predictors in patients with an initial diagnosis of autoimmune encephalitis", Front Immunol, 10, pp.1286~ (2019)
- Nosadini M, "Immune therapy in autoimmune encephalitis : a systematic review", Expert Rev Neurother, 15, pp.1391~1419 (2015)
- Kim SY, "Screening autoimmune anti-neuronal antibodies in pediatric patients with suspected autoimmune encephalitis", J Epilepsy Res, 4, pp.55~61 (2014)
- Lee SK, "The laboratory diagnosis of autoimmune encephalitis", J Epilepsy Res, 6, pp.45~50 (2016)
- Barbagallo M, "Pediatric autoimmune encephalitis", J Pediatr Neurosci, 12, pp.130~134 (2017)
- Armangue T, "Autoimmune encephalitis in children", J Child Neurol, 27, pp.1460~1469 (2012)
- Dalmau J, "NMDA receptor encephalitis and other antibody-mediated disorders of the synapse : the 2016 Cotzias Lecture", Neurology, 87, pp.2471~2482 (2016)
- Miya K, "Anti-NMDAR autoimmune encephalitis", Brain Dev, 36, pp.645~652 (2014)
- Titulaer MJ, "Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis : an observational cohort study", Lancet Neurol, 12, pp.157~165 (2013)
- Gastaldi M, "Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis : a multicenter retrospective study", Eur J Neurol, 27, pp.633~643 (2020)
- Zuliani L, "Management of antibody-mediated autoimmune encephalitis in adults and children : literature review and consensus-based practical recommendations", Neurol Sci, 40, pp.2017~2030 (2019)
- Shin YW, "Treatment strategies for autoimmune encephalitis", Ther Adv Neurol Disord, 11, pp.1756285617722347~ (2017)
- Gabilondo I, "Analysis of relapses in anti-NMDAR encephalitis", Neurology, 77, pp.996~999 (2011)
- Bien CG, "Autoimmune encephalitis in children and adolescents", Neurol Res Pract, 2, pp.4~ (2020)
- Lee WJ, "Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort", Neurology, 86, pp.1683~1691 (2016)
- de Bruijn MAAM, "Pediatric autoimmune encephalitis : recognition and diagnosis", Neurol Neuroimmunol Neuroinflamm, 7, pp.e682~ (2020)
- Armangue T, "Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies : a multicentre observational study", Lancet Neurol, 19, pp.234~246 (2020)
- Eric Lancaster, "Te Diagnosis and Treatment of Autoimmune Encephalitis", Journal of Clinical Neurology, 12(1), pp.1~13 (2016), 대한신경과학회[DOI]